Original Source(s)
Related Content
CGM Linked to More Time in Range
In a randomized crossover trial of insulin-treated patients receiving hemodialysis, real-time continuous glucose monitoring did not improve the primary hypoglycemia outcome but increased time in range and reduced time above range vs capillary testing.
July 14, 2026
-
4 min
Oral Aleniglipron Reduced Weight at 36 Weeks
In a phase 2b trial, the highest dose produced an estimated 12% mean weight reduction vs 1% with placebo, although gastrointestinal adverse events were common.
July 16, 2026
-
6 min
CDC Updates Cyclosporiasis Surveillance
More than 5,100 additional reports require further analysis as federal and state partners investigate several outbreaks and work to identify their sources.
July 15, 2026
-
3 min